StocksH › HLIT

Harmonic Inc. (HLIT) — Earnings Call X-Ray

Our AI read all 38 of HLIT's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q1 2025 · sign up to see
Previous Call Grade
F
Q4 2024
Expected Move
🔒
next 45 days · members
Calls Analyzed
38
2016–2025
Avg Candor
6.9/9
evasion 3/9
Guidance LoweredHigh CandorCritic AmmunitionEarly Product, Fast GrowthMargins ExpandingDemand SlowingReads RehearsedQuestion Left Hanging

Call-by-call analysis

🔒 Q1 2025 earnings call 2025-04-28 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q1 2025 call grade is ready
The full 37-point AI read of HLIT's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

F Q4 2024 earnings call 2025-02-10 move ±20.8%

Management lowered guidance against slowing demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: slowingMargins: expandingBacklog: stablePricing: stable 4 analysts · 10 questions
⚑ Critic ammunition⚑ Question left hanging✓ Early product, fast growth⚑ Reads rehearsedDirection beats results
Candor 7/9
Specificity 8/9
Evasion 4/9
Confidence 6/9
Uncertainty 5/9
Promotion 5/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q3 2024 earnings call 2024-10-29 move ±17.1%

Management raised guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: raisedDemand: mixedMargins: expandingBacklog: stablePricing: stableHeadcount: cutting 5 analysts · 13 questions
⚑ Critic ammunition⚑ Question left hanging✓ Early product, fast growth⚑ Reads rehearsedCFO dominates
Candor 7/9
Specificity 8/9
Evasion 5/9
Confidence 6/9
Uncertainty 6/9
Promotion 5/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C Q2 2024 earnings call 2024-07-29 move ±25.6%

Management held guidance steady against accelerating demand and expanding margins. The delivery was rich in specifics.

Guidance: maintainedDemand: acceleratingMargins: expandingBacklog: stablePricing: stableHeadcount: cutting 5 analysts · 16 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead
Candor 6/9
Specificity 8/9
Evasion 5/9
Confidence 7/9
Uncertainty 3/9
Promotion 4/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C+ Q1 2024 earnings call 2024-04-29 move ±22.2%

Management gave no formal guidance against accelerating demand. The delivery was unusually candid, rich in specifics.

Guidance: mixedDemand: acceleratingMargins: stableBacklog: growingHeadcount: cutting 5 analysts · 12 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Volume step-up ahead
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 7/9
Uncertainty 4/9
Promotion 6/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
From the research question bank
1 more research questions answered NO

C+ Q4 2023 earnings call 2024-01-29 move ±10.1%

Management held guidance steady against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: mixedMargins: contractingBacklog: growingPricing: stableCapex: flat 5 analysts · 13 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Volume step-up ahead
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 8/9
Uncertainty 3/9
Promotion 5/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q3 2023 earnings call 2023-10-31 move ±13.4%

Management lowered guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: mixedMargins: contractingBacklog: stablePricing: stable 5 analysts · 9 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Volume step-up ahead
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 7/9
Uncertainty 4/9
Promotion 6/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q2 2023 earnings call 2023-07-31 move ±26.3%

Management lowered guidance against slowing demand and expanding margins. The delivery was rich in specifics.

Guidance: loweredDemand: slowingMargins: expandingBacklog: growingPricing: stableCapex: flat 6 analysts · 12 questions
⚑ Critic ammunition⚑ Question left hanging✓ Prepayments growing✓ Volume step-up ahead✓ Early product, fast growth⚑ Reads rehearsed
Candor 6/9
Specificity 7/9
Evasion 5/9
Confidence 7/9
Uncertainty 5/9
Promotion 6/9
Stress 4/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q1 2023 2023-05-08 B raisedacceleratingexpanding 7/9 3/9
Q4 2022 2023-01-30 C maintainedacceleratingexpanding 6/9 5/9
Q3 2022 2022-10-31 B+ raisedacceleratingexpanding 7/9 2/9
Q2 2022 2022-08-01 B+ raisedacceleratingstable 7/9 2/9
Q1 2022 2022-05-02 A raisedacceleratingcontracting 8/9 2/9
Q4 2021 2022-01-31 B raisedacceleratingcontracting 7/9 3/9
Q3 2021 2021-11-01 B+ raisedacceleratingcontracting 7/9 3/9
Q2 2021 2021-08-02 B+ raisedacceleratingexpanding 7/9 2/9
Q1 2021 2021-05-03 B+ raisedacceleratingcontracting 8/9 2/9
Q4 2020 2021-02-01 B+ raisedacceleratingexpanding 7/9 3/9
Q3 2020 2020-10-26 A raisedacceleratingexpanding 6/9 3/9
Q2 2020 2020-08-03 B maintainedmixedexpanding 7/9 2/9
Q1 2020 2020-04-27 C withdrawnmixedcontracting 8/9 1/9
Q4 2019 2020-02-03 C+ maintainedacceleratingexpanding 6/9 3/9
Q3 2019 2019-10-28 B+ raisedacceleratingexpanding 7/9 2/9
Q2 2019 2019-07-29 B raisedmixedexpanding 7/9 3/9
Q1 2019 2019-04-29 D loweredmixedstable 7/9 2/9
Q4 2018 2019-02-04 D nonemixedexpanding 6/9 3/9
Q3 2018 2018-10-29 B+ raisedacceleratingcontracting 7/9 2/9
Q2 2018 2018-07-30 B+ raisedacceleratingexpanding 7/9 2/9
Q1 2018 2018-04-30 C+ maintainedacceleratingexpanding 7/9 4/9
Q4 2017 2018-02-28 D maintainedacceleratingcontracting 7/9 4/9
Q3 2017 2017-10-30 D maintainedmixedexpanding 7/9 4/9
Q2 2017 2017-07-31 D loweredmixedcontracting 7/9 2/9
Q1 2017 2017-05-01 C maintainedmixedcontracting 7/9 2/9
Q4 2016 2017-02-28 C maintainedmixedexpanding 7/9 3/9
Q3 2016 2016-11-09 C maintainedmixedcontracting 7/9 2/9
Q2 2016 2016-08-09 C+ raisedacceleratingstable 7/9 6/9
Q1 2016 2016-05-10 D maintainedacceleratingcontracting 7/9 3/9
Q4 2015 2016-02-17 C+ nonemixedstable 7/9 2/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of HLIT's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

B+ Q2 2022 earnings call 2022-08-01

C Q1 2020 earnings call 2020-04-27

1 more research questions answered NO

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAMC · Altisource Asset ManagemAAON · AAON, Inc.AASZF · Atlantic Sapphire ASAAAT · American Assets Trust, IABCD · Cambium Learning Group'sABCO · The Advisory Board

HLIO   All “H” companies    HLIX

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.